Dr Howard I. Scher, Chief, Genitourinary Oncology Service; D. Wayne Calloway Chair in Urologic Oncology, Sloan Kettering The benefits of liquid biopsies for lung cancer in the community setting
cfDNA & CTC by the LiquidBiopsy Platform | AACR 2015 Highlighting the Clinical Utility of Liquid Biopsies for Biomarker Detection in NSCLC Molecular profiling of tumor biomarkers in head and neck cancer
Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, discusses the clinical relevance of The AACR Cancer Progress Report 2018 highlights how research discoveries are driving progress through the development of A Liquid Biopsy-based Assay Could Detect Recurrence Prior to
Abstract 1026: Multi-modal liquid biopsy analysis of early-stage Mouadh Barbirou, PhD, Thomas Jefferson University, Philadelphia, PA, examines the epigenomic and genomic profiles of tumor
Potential trends in the molecular profiling of breast cancer Simultaneously isolating cfDNA and Circulating tumor cells (CTCs) from a Single Sample | AACR 2015 Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, outlines the different circulating
Liquid Biopsy in Cancer Care Sofia Mastoraki, PhD, University of Texas MD Anderson Cancer Center, Houston, TX discusses molecular profiling and the need Paolo Marchetti, MD, PhD, IDI-IRCCS, Rome, Italy, discusses an analysis from the ROME trial (NCT04712864), which evaluated
A career development grant from the AACR initiated the development of a model to help understand one of the deadliest and most AACR 2024 Spotlight Theater Arpit Rao, MD, University of Minnesota, Minnesota, MN, talks on the clinical utility of liquid biopsies in prostate cancer, which
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis AACR 2018 - Thomas Schlange about the CANCER-ID initiative UCSF at #AACR25: Laura Huppert, MD | Liquid Biopsy: Circulating Tumor Cells
Klaus Pantel, Chairman of the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf, reviews how liquid Inocras introduces clinical validation of their MRDVision assay. MRDVision is a whole-genome based, panel-free, tumor-informed Cancer in a Drop: Liquid biopsy insights from AACR 2025 - PMC
Earn CME credit for a related activity: In this presentation from Lymphoma & Myeloma 2018, Dr. Envisioning Innovation Through Cross-disciplinary Team Science
David Polsky MD,PhD Professor of Cutaneous Oncology at NYU discusses the role of Circulating Tumor DNA and Liquid Biopsy Webinar: Stephen Bagley, MD - Liquid Biopsy for Brain Tumors: Recent Advances and Future Directions Leveraging Liquid Biopsy to Improve Cancer Care | Blog | AACR
Hear from Prof. Nir Peled, an eminent oncologist from Israel, as he shares his views on the important role of liquid biopsy in The American Association for Cancer Research released its annual Cancer Progress Report – cancerprogressreport.org – at a
Martha Chekenya, PhD, University of Bergen in Bergen, Norway, discusses the next steps following the Phase I/II clinical trial AACR 2009: Circulating tumour cells as biomarkers April 21, 2025. Laura Huppert, a breast medical oncologist at UCSF, will be presenting "Development of a novel assay to detect
The Important Role of Liquid Biopsy in Clinical Practice Andrew Rhim, M.D., Assistant Professor of Internal Medicine and Assistant Director for Translational Research, University of
Stephen Bagley, MD, MSCE, Assistant Professor of Medicine at the University of Pennsylvania, provides an overview of the AACR 2024: An exosome-based liquid biopsy shows promise for
Dr. Elaine Mardis, chair of this year's AACR Program Committee, talks about the hot topics for AACR 2018, technological hurdles Integrating tissue and liquid biopsies in solid tumor management
Research presented at the AACR Annual Meeting 2021 highlights the great potential of liquid biopsy to benefit patients across the An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA
Highlights of the EORTC-NCI-AACR Symposium Challenges in implementing liquid biopsies for head and neck cancer
Inocras AACR 2025 MRD AACR Grant Propels Progress in Pancreatic Cancer Research AACR 2018 QIAGEN boothtour with Lee-Anne
Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on combining tumor-specific This talk highlights two different oncology research applications for Roche's Digital LightCycler® dPCR System. First, Yu Zhao Program Precision Med 2020 | Meetings | AACR
Visit for more. Prof Gordon McVie of ecancer summarises the highlights of the 26th EORTC-NCI-AACR The AACR Special Conference on Advances in Liquid Biopsies ( held January 12-16, 2020 in Miami, Clinical utility of liquid biopsies in prostate cancer
Ezra Cohen, MD, FRCPSC, FASCO, Moores Cancer Center at UC San Diego Health, San Diego, CA, comments on how liquid Liquid biopsy in daily clinical practice
AACR Cancer Progress Report 2018 Congressional Briefing Identifying molecular biomarkers for treatment response to bortezomib in glioblastoma
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer care. Hot Topics at AACR 2018 with Dr. Elaine Mardis
Challenges to implementing liquid biopsy in clinical practice Advances in Liquid Biopsies
ROME: integrating tissue and liquid biopsies in precision oncology Jason Johnson of Thermo Fisher Scientific talks about finding circulating tumor cells with as few as 20 cells with the LiquidBiopsy Highlights the most recent research efforts presented at the AACR Annual Meeting 2025, focusing on liquid biopsy (LB) methods and applications.
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1026. ©2025 American Association for Cancer Research. American Association for Cancer Research President Elaine R. Mardis, PhD, FAACR, discusses the importance of federal Prof Klaus Pantel presents at ecancer's Milan Summit on Precision Medicine 2018 about the potential advances in liquid biopsy
Cancer in a Drop: Liquid biopsy insights from AACR 2025 Learn more in
Researchers are finding innovative ways turn the great potential of liquid biopsy into real benefit for patients across the continuum Liquid biopsies for the detection of precancerous lesions
Dr Nilsson talks to ecancertv at AACR 2015 about the development of a blood test which regularly monitors for the presence of the Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, the possible clinical applications of Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
Mouadh Barbirou, PhD, Thomas Jefferson University, Philadelphia, PA, provides an overview of remaining hurdles in Improving the selection process for adjuvant checkpoint inhibition Panel examines emerging clinical applications of liquid biopsy
Researching Liquid Biopsy in Cancer Care Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
UCSF at #AACR25: Rensheng Wan, PhD, on Women in Cancer Research Award and Mentorship Opportunities Stanford Surgery's Chief of Surgical Oncology Research discusses the past and future of liquid biopsy. For more information about
Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, outlines the main challenges for The American Association for Cancer Research exhibit hall debuted the new LiquidBiopsy™ Platform, and in this video Vidya The Promise of Liquid Biopsy
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance The future of liquid biopsies in head and neck cancer What is the LiquidBiopsy Platform? - AGBT 2015
While tissue biopsies remain the gold standard of cancer diagnostics, liquid biopsy More from the AACR Annual Meeting 2025 · View a photo New findings on the utility of circulating biomarkers for liquid biopsy
An ultrasensitive ctDNA-based liquid biopsy assay detected signs of recurrence prior to imaging and provided prognostic value within one This Special Conference will be unique as it is the first program designed to address traditional cancer research topics such as trial design, diagnostics,
AACR Exhibitor Spotlight Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky
Will liquid biopsy replace traditional diagnostic tools? Challenges in Liquid Biopsy
Paolo Marchetti, MD, PhD, IDI-IRCCS, Rome, Italy, discusses the potential of combined biopsy approaches in advanced tumor Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, summarises the recent updates on Nickolas Papadopoulos, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, talks on whether liquid biopsies
Cancer in a Drop: Liquid biopsy insights from AACR 2025. In this interview André de Fusco and Dr. Paul Dempsey (CEO and CSO of Cynvenio Biosystems Inc.) share their perspective on
Promising new circulating biomarkers for liquid biopsy The lack of common standards creates a major obstacle for the broader use of liquid biopsies in clinical settings. Dr. Thomas Policy Briefing: AACR Cancer Progress Report 2022
Liquid Biopsy 2024 | Meetings | AACR AACR Workshop: Ultra-low Input Targeted Genomic Analysis for Pancreatic Cyst Lesions and Cancer
AACR 2021 Product Demo: Overview of ImmunoID NeXT Platform. This conference brings together leaders in the field to share the latest advancements in liquid biopsies encompassing the spectrum from discovery to clinical
Dr. Stefanie Jeffery: Integration of Liquid Biopsy into Clinical Cancer Care April 2025. Rensheng Wan, a postdoctoral scholar in Dr. David Quigley's lab at UCSF, presented herwork on using methylation Abstract 6372: Combined tissue and liquid biopsy improves
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6372. ©2025 American Association for Cancer Research. Alain Thierry, PhD, INSERM U896 - IRCM, Montpellier, France, briefly comments on the breakthrough role of liquid biopsy
AACR 2021 Product Demo During the 2019 AACR Annual Meeting, Vassiliki Papadimitrakopoulou, MD, professor of medicine, Department of Thoracic/Head Deepti Behl, MD, Sutter Sacramento Medical Center, Sacramento, CA, comments on the role of liquid biopsies for lung cancer.
Genomics 101: From deep sequencing to liquid biopsies QIAGEN's Lee-Anne Zinetti walks through QIAGEN's Sample to Insight offering at AACR 2018 and explains what the company
The liquid biopsy has the potential to change cancer research and clinical care through a variety of applications, from early